Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Auteurs

E. Saâda-Bouzid, C. Defaucheux, A. Karabajakian, V.P. Coloma, V. Servois, X. Paoletti, C. Even, J. Fayette, J. Guigay, D. Loirat, F. Peyrade, M. Alt, J. Gal, C. Le Tourneau